Microbiology & Pathology in California

Diagnostic Automation / Cortez Diagnostics, Inc. (DACD) is a global diagnostic test kit manufacturer founded in 1989, serving research labs, hospitals, clinical laboratories, and physicians across 168 countries. The company specializes in producing ELISA kits, rapid test kits, chemiluminescence immunoassay (CLIA) kits, serology tests, and immunofluorescence assay (IFA) kits. DACD offers both consumable diagnostic test kits and associated instruments for clinical laboratory use. The product portfolio addresses infectious disease serology, immunological testing, and general clinical diagnostics. The company emphasizes quality assurance, competitive pricing, fast shipping, and technical customer support. DACD maintains manufacturing and distribution operations from its Woodland Hills, California headquarters and distributes globally through a network of respected distributors. The company is privately held and committed to continuous innovation in diagnostic testing methodologies.

Monobind Inc. is a leading independent in vitro diagnostics (IVD) manufacturer founded in 1978 and headquartered in Lake Forest, California. The company develops and manufactures over 160 immunoassay products across its AccuBind® ELISA and AccuLite® CLIA platforms, serving clinical laboratories, point-of-care facilities, and direct-to-patient applications globally. Monobind's portfolio spans multiple assay formats—microplate, monotest, magnetic-bead, lateral flow assays (LFA), and microarray technologies—enabling testing of serum, plasma, and whole blood samples. The company supports scalable workflows from manual reader-based systems to fully automated random-access analyzers. Beyond finished assays, Monobind supplies high-quality biomaterials and specialty reagents including buffers and stabilizers for the global diagnostics industry. Operating under FDA registration and ISO 13485 certification, the company distributes CE-marked products to laboratories and partners in over 100 countries worldwide.

Zeta Corporation is an ISO 13485:2016 and FDA-registered biomedical manufacturer specializing in precision recombinant in vitro diagnostic (IVD) antibodies for immunohistochemistry (IHC) applications. The company develops and distributes a portfolio of over 400 tumor and tissue-specific IVD recombinant antibodies designed for anatomic pathology laboratories. Zeta's product lines include MonoMAb™ monospecific mouse monoclonal antibodies and RAbMono™ rabbit monoclonal antibodies, both engineered for high specificity, sensitivity, and reproducibility on formalin-fixed, paraffin-embedded (FFPE) tissue sections. All antibodies are rigorously validated and target-verified by pathologists to ensure consistent, reliable diagnostic results. With over 75 years of collective scientific expertise, Zeta manufactures antibodies using recombinant production methods for rapid, reliable manufacturing and distributes directly in the United States and through trusted partners to over 50 countries worldwide.

ML LifeSciences is a contract manufacturer specializing in custom sterile reagents and media for clinical, diagnostic, biotech, veterinary, and quality control laboratory applications. The company offers terminal sterilization, aseptic fills, universal transport media, and compounded reagents across traditional and emerging formulations. Manufacturing capabilities span the full product lifecycle: raw material sourcing, formulation, sterile manufacturing, and packaging in client-specified containers including syringes, transport vials, tubes, PVC and EVA solution bags, and polycarbonate bottles. The company serves clinicians, researchers, laboratory professionals, and diagnostic laboratories with custom solutions for QC, diagnostic, biotech, and veterinary applications. ML LifeSciences is ISO 9001 certified and maintains compliance with federal and state regulatory agencies, ensuring rigorous manufacturing standards and quality control. The company emphasizes on-time delivery, consistent product quality, and superior value for demanding and time-critical projects.

Illumina, Inc. is a global leader in DNA sequencing and array-based genomic analysis, providing comprehensive solutions for research, clinical diagnostics, and precision health applications. The company manufactures next-generation sequencing (NGS) platforms ranging from benchtop to production-scale instruments, microarray systems for genetic analysis, and library preparation kits optimized for diverse DNA and RNA workflows. Illumina's product portfolio includes the TruPath Genome solution, Single Cell 3' RNA Prep kits, and associated bioinformatics software for data analysis and insights. The company serves academic research institutions, clinical laboratories, pharmaceutical companies, and healthcare providers globally, enabling applications in cancer research, genetic disease testing, infectious disease surveillance, reproductive health, and precision medicine. Illumina offers 24/7 technical support, comprehensive documentation, training resources, and multiple financing options for instrument acquisition. The company maintains regulatory compliance with FDA clearances and international standards, and provides worldwide distribution through channel partners and direct sales. Corporate headquarters located in San Diego, CA with regional offices and support centers across North America, Europe, Asia-Pacific, and other global markets.

Avails Medical, Inc. is an in vitro diagnostics company founded in 2013 by Stanford University alumni and based in Menlo Park, California. The company specializes in rapid, automated antibiotic susceptibility testing (AST) technologies aimed at addressing antimicrobial resistance and improving outcomes for sepsis patients. Their innovative all-electrical biosensor platform streamlines the testing process by eliminating manual culturing steps, allowing for faster pathogen quantification and susceptibility testing directly from human specimens. The flagship product, the eQUANT™ System, is an FDA-cleared electronic biosensor that provides results in approximately 70 minutes, significantly reducing turnaround time for testing common gram-negative bacteria. This system is designed for easy integration into laboratory workflows and supports timely diagnostics, which can lead to better patient outcomes and lower healthcare costs. Each minute of diagnostic delay increases sepsis mortality risk; Avails Medical's rapid AST platform addresses the critical clinical need for accelerated antimicrobial susceptibility identification in blood culture specimens, with documented multicenter validation.

BioGenex Laboratories is a US-based manufacturer of in vitro diagnostic instruments, reagents, and detection kits for immunohistochemistry (IHC), in situ hybridization (ISH), fluorescent in situ hybridization (FISH), and multiplex molecular diagnostics. The company serves pathology laboratories, research institutions, and clinical diagnostics centers globally, with offices in Fremont (CA), India, and China. BioGenex produces a comprehensive portfolio of automated staining instruments (Xmatrx® Elite, i6000™, NanoVip™, Neuvo), detection kits, monoclonal and polyclonal antibodies, ISH and FISH probes, antigen retrieval systems (EZ-RT), and ancillary reagents. Products are designed for tumor diagnosis, biomarker panel testing, and gene expression analysis on formalin-fixed, paraffin-embedded (FFPE) tissue specimens. The company offers sales support, technical support, comprehensive training programs, and field service including on-site installation, maintenance, and troubleshooting. Customer base includes major academic medical centers (Mayo Clinic, Cleveland Clinic, Stanford Healthcare, MD Anderson), national reference laboratories (Quest Diagnostics, LabCorp), and hospital systems. BioGenex maintains rigorous product testing and provides operator manuals, scientific literature, and technical documentation.

Q.I. Medical manufactures specialized products for pharmacists, nurses, and pharmacy technicians handling sterile solutions. The company focuses on devices, test kits, and accessories that improve aseptic technique and validate compliance with USP Chapters 795, 797, 800, and 71. Product applications include environmental monitoring and surface sampling, gloved fingertip testing, sterility and endotoxin testing, TPN process validation, media fill testing for aseptic technique validation, incubation systems, and needleless dispensing solutions. Q.I. Medical serves institutional pharmacy and compounding operations requiring documented quality assurance and regulatory compliance.

Aiken Corporation is a Southern California-based laboratory equipment manufacturer founded in 1988. The company manufactures and exports a comprehensive range of general laboratory equipment using domestic and foreign components, serving hospitals and clinical laboratories in over 60 countries. Product lines include autoclaves, centrifuges, incubators, dry ovens, water and oil baths, biological safety cabinets, microscopes, tissue processors, balances, pH meters, conductivity meters, spectrophotometers, pipettes, refrigerators, and water purification systems. Additional offerings include microtomes, oscillators, polarimeters, clean benches, ultrasonic water baths, water distillers, and PRP (platelet-rich plasma) processing equipment. Aiken provides customer service Monday–Friday, 8:30 am–5 pm PST, including technical support, field service, maintenance, repair, and troubleshooting. The company emphasizes equipment reliability, operational performance, and total cost reduction for laboratory operations. Distribution is global, with manufacturing networks serving domestic and international markets.

Epitope Diagnostics Inc. is an ISO 13485:2016 certified and FDA-registered medical device manufacturer specializing in niche immunoassays for clinical diagnostics and research communities. Headquartered in San Diego, California, the company manufactures chemiluminescence immunoassay kits, automated ELISA kits, lateral flow rapid test kits (EPITUUB® US patented), and specialty antibodies. Product portfolios span tumor markers and cancer research, gastrointestinal disease diagnostics, infectious disease testing, cardiovascular disease markers, calcium and bone metabolism assays, endocrinology and diabetes testing, autoimmune disease panels, and anemia diagnostics. The company serves both USA and international markets through separate product catalogs and maintains automation and analyzer platforms alongside traditional immunoassay methodologies. All products are designed for professional laboratory use in clinical and research settings. The company maintains full regulatory compliance with FDA licensing and ISO quality management systems certification valid through June 2026.

Lumatas BioSystems is a Silicon Valley-based manufacturer of fully automated biomedical laboratory equipment specializing in immunohistochemistry (IHC) staining systems. The company designs and produces automated IHC autostainers that enable pathology laboratories and hospitals to perform rapid, consistent immunohistochemistry procedures for tissue antigen detection and localization. Their primary product line consists of the Titan and Titan S, fully automated IHC autostainers used for diagnostic purposes in cancer detection and other disease diagnosis. The Titan processes up to 30,000 slides per unit annually with 72-slide capacity and up to 70 reagent positions, while the Titan S is a compact variant with 36-slide capacity and up to 42 reagent positions, designed for smaller laboratory footprints. Both systems offer heating capability from 0°C to 103°C and operate on standard 220–240 VAC power. Lumatas systems are engineered to deliver high throughput, accuracy, and consistency in antibody-antigen interaction analysis for histopathology workflows. The company partners with Maxim Biotechnologies for distribution and support in international markets.

BioLegend is a biomedical research company specializing in the development and manufacturing of research reagents and antibodies for scientific investigations. The company operates a modern manufacturing facility in San Diego, California, and offers a comprehensive portfolio including monoclonal and polyclonal antibodies, immunoassay solutions, recombinant proteins, magnetic cell separation products, and single-cell proteogenomics reagents. BioLegend serves research institutions, pharmaceutical companies, and clinical laboratories across multiple therapeutic areas including neuroscience, oncology, immunology, stem cell research, and clinical diagnostics. The company has acquired the Covance antibody product portfolio to strengthen its neuroscience offerings and collaborates with leading research organizations such as The Michael J. Fox Foundation for Parkinson's Research and Illumina. BioLegend provides IVD (in vitro diagnostic) reagents and ASR (Analyte Specific Reagent) products for immunohistochemistry, immunophenotyping, and flow cytometry applications. The company emphasizes quality manufacturing, expert technical support, and custom product development services to support precision medicine, oncology, and biomedical discovery.

IVD Research, Inc. is an ISO 13485 certified contract manufacturer and original equipment manufacturer (OEM) specializing in the development, manufacture, and marketing of in vitro diagnostic (IVD) assays and laboratory solutions. Founded in 1996, the company operates as an FDA Registered Manufacturer under current Good Manufacturing Practices (cGMP). IVD Research develops and manufactures detection assays for global pathogens across multiple diagnostic technologies, serving customers from R&D through full commercialization. The company offers comprehensive contract manufacturing services including custom assay development, process optimization, and turnkey manufacturing solutions tailored to client specifications. Their expertise spans multiple assay formats and detection methodologies for clinical and research applications. IVD Research emphasizes quality management system compliance, regulatory adherence, and custom-tailored solutions designed to meet specific customer requirements rather than one-size-fits-all approaches. The company provides expert technical support and maintains a commitment to delivering consistent, high-quality diagnostic products with accuracy and reliability. Services include partial manufacturing support through complete product development and commercialization assistance.

ImmunoCentrix Corporation is an FDA-registered manufacturer and distributor of in-vitro diagnostic (IVD) devices headquartered in Canoga Park, California. The company specializes in immunodiagnostic and research products across five core technology platforms: Enzyme-Linked Immunosorbent Assay (ELISA), Chemiluminescence Immunoassay (CLIA), Immunofluorescence (IFA), Rapid Tests, and Serology assays. Their product portfolio exceeds 100 immunodiagnostic and research products targeting infectious disease, parasitology, and autoimmune disease diagnostics. ImmunoCentrix maintains FDA registration and holds ISO 13485:2016 and ISO 9001:2015 certifications, demonstrating compliance with medical device manufacturing quality and management system standards. The company manufactures products under strict ISO and FDA quality requirements and distributes globally through direct sales and distributor networks. They offer technical support services and competitively priced products designed for clinical laboratories, research institutions, and diagnostic centers. Manufacturing capabilities encompass bulk reagent preparation and quality assurance protocols consistent with IVD device regulatory requirements.

Copan Group is a preanalytics and microbiology solutions provider founded in 1979, specializing in sample collection, transport systems, and diagnostic consumables for clinical laboratories, pharmaceutical, food, and personal care industries. The company manufactures proprietary sample collection and transport devices, including its flagship FLOQ® Technology for improved sample efficiency. Copan offers enrichment broths and culture media (including LBM® technology for selective cultivation such as Candida auris), molecular testing solutions (UBM™ non-toxic medium), and digital microbiology platforms. The company serves clinical labs with solutions for respiratory infections, antibiotic resistance testing, self-collection systems, clinical automation, and molecular biology applications. Copan also provides business alliances and custom collection devices for proprietary laboratory workflows. The company emphasizes quality certifications, regulatory compliance, R&D innovation through its "Science and R&D" program, and operates the CoScience HUB knowledge-sharing platform for microbiology excellence. Copan maintains ISO and quality compliance frameworks and participates in major scientific conferences (e.g., ESCMID). The organization pursues incubation and acceleration initiatives through its Futura Invent program.